DOH eyes Q1 or Q2 2021 for COVID-19 vaccine rollout

Health Secretary Francisco Duque III stated that the Philippines' COVID-19 vaccination program could commence within the first quarter or at the start of the second quarter of 2021.

This timeline is considered the best-case scenario, as inoculating the 60 to 70 million Filipinos needed will be a lengthy process.

The government aims to secure a diverse portfolio of vaccines, with potential candidates including Sinovac, Gamaleya, AstraZeneca, Sinopharm, and Johnson & Johnson.

Several of these selected vaccines are advantageous because they require less sophisticated cold storage temperatures compared to the Pfizer-BioNTech vaccine.

However, the Pfizer-BioNTech vaccine, along with those from Moderna and AstraZeneca-Oxford, have shown over 90% effectiveness in trials.

The ultra-low freezer requirement for Pfizer-BioNTech and Moderna vaccines presents a challenge for the Philippines, though Pfizer may provide assistance with cold storage.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.